AH: Cluster Immunotherapy and its Application in Clinical Practice
Allergens/Allergy Testing/Allergy Therapeutics
Saturday, March 3, 2018: 2:00 PM-3:15 PM
Hyatt, Convention Level, Plaza I
1.25 CME/CE
Kim E. Mudd, RN MSN

Learning Objectives:
  1. Describe the role of accelerated buildup regimens such as cluster IT for initiating subcutaneous immunotherapy
  2. Discuss the current results of the ACAAI/AAAAI surveillance study for immunotherapy safety
  3. Discuss the requirements for compliance with the USP Chapter 797 immunotherapy compounding
2:00 PM
Accelerated Buildup Regimens for SCIT and their Application in Clinical Practice
Justin C. Greiwe, MD
2:20 PM
Question & Answer
2:25 PM
ACAAI/AAAAI Surveillance Study of Immunotherapy Safety
David I. Bernstein, MD FAAAAI
2:45 PM
Question & Answer
2:50 PM
USP Chapter 797 Immunotherapy Update
Cheryl K. Bernstein, RN BSN CCRC
3:10 PM
Question & Answer
See more of: Session